Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after repeated SARS-CoV-2 mRNA vaccinationAnother IgG4 paper.Mathew AldredOct 25, 2023∙ Paid91ShareThis post is for paid subscribersAlready a paid subscriber? Sign in